These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 26592251)
1. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
3. Betaine homocysteine methyltransferase (BHMT)-dependent remethylation pathway in human healthy and tumoral liver. Pellanda H Clin Chem Lab Med; 2013 Mar; 51(3):617-21. PubMed ID: 23449526 [TBL] [Abstract][Full Text] [Related]
4. A splicing variant leads to complete loss of function of betaine-homocysteine methyltransferase (BHMT) gene in hepatocellular carcinoma. Pellanda H; Namour F; Fofou-Caillierez M; Bressenot A; Alberto JM; Chéry C; Ayav A; Bronowicki JP; Guéant JL; Forges T Int J Biochem Cell Biol; 2012 Feb; 44(2):385-92. PubMed ID: 22138536 [TBL] [Abstract][Full Text] [Related]
5. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
7. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis. Jin Y; Li Q; Qiu J; Zhao X; Zheng C; Lv S; Bai Y; Shan Y; Ye LC Tumour Biol; 2016 Oct; 37(10):14193-14203. PubMed ID: 27553024 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma. Liu Y; Jiang P; Wang G; Liu X; Luo S Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis. Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666 [TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
12. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of betaine-homocysteine methyltransferase activates glucose-6-phosphate dehydrogenase (G6PD) by decreasing arginine methylation of G6PD in hepatocellular carcinogenesis. Gao J; Shi X; Sun Y; Liu X; Zhang F; Shi C; Yu X; Yan Z; Liu L; Yu S; Zhang J; Zhang X; Zhang S; Guo W Sci China Life Sci; 2024 Aug; 67(8):1648-1665. PubMed ID: 38679670 [TBL] [Abstract][Full Text] [Related]
15. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis. Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma. Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619 [TBL] [Abstract][Full Text] [Related]
17. Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma. Wang JH; Wei W; Guo ZX; Shi M; Guo RP J Transl Med; 2015 Feb; 13():41. PubMed ID: 25638165 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
19. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
20. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]